Department of Psychiatry & Human Behavior
The department is fully dedicated to carrying out the mission of Thomas Jefferson University, Thomas Jefferson University Hospital, and the Jefferson Health Care Network.
The department is made up of many skilled physicians, psychologists, a social worker, a nurse practitioner, researchers, and dedicated support staff. Faculty and staff have family, psychiatric, and mental health specialties.
43rd Annual Albert M. Biele, MD, Memorial Lectureship Event
Wednesday, December 14th, 2022 -- 11:00 am - 12:30 pm
The Descent of Agamemnon and the Disquietude of Job: The Death of Agency as the Spur of Suicide -
Thomas Joiner, PhD
This is a special IN-PERSON event, held at:
College Building, Ground Floor
1025 Walnut Street, Philadelphia 19107
About Thomas Joiner, PhD - An internationally recognized researcher and clinician on the topic of suicide, Dr. Joiner has advanced the most widely recognized contemporary theory of the pathophysiology of suicide. Dr. Joiner currently serves as the the Robert O. Lawton Distinguished Professor of Psychology as well as Director of the Psychology Clinic at Florida State University.
Please contact Annalee.Locke@jefferson.edu for how to watch the lecture virtually, or with any questions or concerns.
Our Support Takes the Following Forms
We provide medical students, residents, and fellows with a rich and rewarding educational experience as they rotate through all our clinical services: Adult (Inpatient and Outpatient); Emergency; Consultation-Liaison; Substance Abuse; Pain; Child and Adolescent; Sleep Disorders; and various specialty electives. All our residency and fellowship programs are approved by the Accreditation Council for Graduate Medical Education's Residency Review Committees. Information on our residency training program can be found on the Residency pages.
We are dedicated to providing excellent psychiatric care to patients in the Delaware Valley area.
The department is focused on clinical research. We investigate the symptoms and treatments of various psychiatric illnesses, including Alzheimer’s disease and novel treatment modalities (MBAT - Mindfulness-Based Art Therapy). Our Mood Disorders Program is conducting innovative research on the identification and treatment of the side effects of psychiatric medications. In addition, it conducts clinical trials of potential new medications for mood disorders.